Scholl Hendrik Peter (CIK 2113223) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-22). Recent activity: Sell BLTE (96 shares), Sell BLTE (3,748 shares), Sell BLTE (4,861 shares), Sell BLTE (1,199 shares), Sell BLTE (96 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 96 | $13,814 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 3,748 | $542,192 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 4,861 | $706,959 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 1,199 | $175,348 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 96 | $14,123 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 2,054 | $282,641 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 784 | $108,331 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 3,140 | $438,260 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 540 | $75,915 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 100 | $14,183 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 450 | $63,988 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 1,897 | $272,314 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 1,035 | $150,097 |
Source: SEC Form 4 filings · as of 2026-06-22